key: cord-0863520-x1jkso3g
authors: Carto, Chase; Nackeeran, Sirpi; Ramasamy, Ranjith
title: COVID‐19 vaccination is associated with a decreased risk of orchitis and/or epididymitis in men
date: 2021-10-20
journal: Andrologia
DOI: 10.1111/and.14281
sha: ab6b0bcaaa285ac671ca4129a4f021f47f3d3b62
doc_id: 863520
cord_uid: x1jkso3g

Vaccine hesitancy is a major public health obstacle to fighting the ongoing COVID‐19 epidemic. Due to studies that show COVID‐19 infection can affect sperm parameters and lead to orchitis, the public are concerned about the effect of the COVID vaccines on male reproduction. In this study, we investigated the association between COVID‐19 vaccination and risk of developing orchitis and/or epididymitis outcomes in a cohort of men using a large, US‐based, electronic health record database. After balancing for confounding variables, we found that receiving at least 1 COVID‐19 vaccine is associated with a decreased risk of developing orchitis and/or epididymitis.

Despite the development of three vaccines to combat the ongoing COVID-19 epidemic, vaccine hesitancy remains the primary public health challenge in slowing the spread of the virus in the United States. Currently, the share of Americans fully vaccinated against COVID-19 is just 54%, and 63% have received at least one dose of a two-dose protocol (Ritchie et al., 2020) . Americans cite many different reasons for choosing whether or not to become vaccinated, but one of the most common concerns is uncertainty or mistrust of how the COVID-19 vaccine may affect fertility (Diaz et al., 2021; Sajjadi et al., 2021) .

The reason for the concern about the negative impact of COVID vaccines on male reproduction is because the COVID-19 virus can adversely affect male fertility (Best et al., 2021) and has been linked to testicular pain/orchitis and epididymitis Bridwell et al., 2021; Pan et al., 2020) . Alternatively, there is no evidence to show that the COVID-19 vaccines cause problems with male fertility (CDC, 2020) . In fact, one study found that there was no significant decrease in sperm parameters after receiving two doses of a COVID-19 mRNA vaccine (Gonzalez et al., 2021) . However, no studies have been performed to our knowledge that assesses the effect of COVID-19 vaccination on orchitis and/or epididymitis. In this study, we investigated whether or not receiving a COVID-19 vaccine was independently associated with development of orchitis and/or epididymitis.

In this comparative cohort study, we queried data from TriNetX LLC Dataworks Network, a US-based health research network that collects de-identified electronic health record data from 46 health-care organisations and has over 70 million records. The TriNetX platform has been used previously to determine outcomes associated with COVID-19 (Annie et al., 2020; Jorge et al., 2021) . We identified male patients ages 12 years and older who received a single-dose COVID-19 vaccine or at least 1 of a 2-dose vaccine regimen using specific ICD-10 medication and procedure codes and compared them with a cohort of men who did not have any COVID-19 vaccine codes in their health record.

The primary outcome for analysis was development of orchitis and/or epididymitis (N45, N45.1, N45.2, N45.3, N45.4 and N51) between 1 and 9 months after the index event of COVID-19 vaccination. Statistical analysis was performed comparing development of orchitis between both cohorts. Odds ratios were calculated both before and after propensity score matching, a technique that utilises logistic regression to construct equivalent cohorts that are matched by potential confounding variables to determine whether any association is independent. We matched the cohorts using the following potentially confounding variables: age, race, urinary tract infection (N39.0) and unspecified sexually transmitted disease (A64) as these variables have been previously identified as risk factors for orchitis independent of receiving the COVID-19 vaccine (Trojian et al., 2009) .

Histopathology and ultrastructural findings of fatal COVID-19 infections on testis

Prevalence and outcomes of acute ischemic stroke among patients ≤50 years of age with laboratory confirmed COVID-19 infection

Evaluation of SARS-CoV-2 in human semen and effect on total sperm number: A prospective observational study

A coronavirus disease 2019 (COVID-19) patient with bilateral orchitis

How to address COVID-19 vaccine misinformation

COVID-19 vaccine hesitancy linked to increased internet search queries for side effects on fertility potential in the initial rollout phase following Emergency Use Authorization

Sperm parameters before and after COVID-19 mRNA vaccination

Temporal trends in severe COVID-19 outcomes in patients with rheumatic disease: A cohort study. The Lancet

No evidence of severe acute respiratory syndrome-coronavirus 2 in semen of males recovering from coronavirus disease 2019

Coronavirus pandemic (COVID-19)

United States internet searches for "infertility" following COVID-19 vaccine misinformation

Epididymitis and orchitis: An overview